Scribd Logo
Upload

Welcome to Scribd!

  • 23 views

    Indonesia: 2017 Tissue Diagnostics IVD Market Size

    Uploaded by

    azika
    The tissue diagnostics IVD market in Indonesia was worth IDR 22.7 billion in 2017. The market is expected to see very high growth rates of over 15% from 2017-2022, driven by increasing cancer prevalence. The top competitors by product segment in 2017 were LEICA, Thermofisher, and Merck in pre-analytical products; Thermofisher, LEICA, and Merck in H&E staining; Merck, DAKO, and - in special stains; Roche, LEICA, and DAKO in IHC; and Roche, DAKO, and Abbott in ISH. The top 5 tissue diagnostics competitors across Asia Pacific in 2017 were Danaher, Roche, Thermo

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd

    Indonesia: 2017 Tissue Diagnostics IVD Market Size

    Uploaded by

    azika
    23 views1 page
    The tissue diagnostics IVD market in Indonesia was worth IDR 22.7 billion in 2017. The market is expected to see very high growth rates of over 15% from 2017-2022, driven by increasing cancer prevalence. The top competitors by product segment in 2017 were LEICA, Thermofisher, and Merck in pre-analytical products; Thermofisher, LEICA, and Merck in H&E staining; Merck, DAKO, and - in special stains; Roche, LEICA, and DAKO in IHC; and Roche, DAKO, and Abbott in ISH. The top 5 tissue diagnostics competitors across Asia Pacific in 2017 were Danaher, Roche, Thermo

    Original Description:

    Original Title

    Untitled

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    The tissue diagnostics IVD market in Indonesia was worth IDR 22.7 billion in 2017. The market is expected to see very high growth rates of over 15% from 2017-2022, driven by increasing cancer prevalence. The top competitors by product segment in 2017 were LEICA, Thermofisher, and Merck in pre-analytical products; Thermofisher, LEICA, and Merck in H&E staining; Merck, DAKO, and - in special stains; Roche, LEICA, and DAKO in IHC; and Roche, DAKO, and Abbott in ISH. The top 5 tissue diagnostics competitors across Asia Pacific in 2017 were Danaher, Roche, Thermo

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    23 views1 page

    Indonesia: 2017 Tissue Diagnostics IVD Market Size

    Uploaded by

    azika
    The tissue diagnostics IVD market in Indonesia was worth IDR 22.7 billion in 2017. The market is expected to see very high growth rates of over 15% from 2017-2022, driven by increasing cancer prevalence. The top competitors by product segment in 2017 were LEICA, Thermofisher, and Merck in pre-analytical products; Thermofisher, LEICA, and Merck in H&E staining; Merck, DAKO, and - in special stains; Roche, LEICA, and DAKO in IHC; and Roche, DAKO, and Abbott in ISH. The top 5 tissue diagnostics competitors across Asia Pacific in 2017 were Danaher, Roche, Thermo

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    of 1

    Tissue Diagnostics Competitive Landscape

    Indonesia: 2017 Tissue Diagnostics IVD Market Size

    Tissue Diagnostics 2017 market size ‘17-’22 forecasted Competitors’ share ranking
    Product segments (IDR bil) growth
    #1 #2 #3

    Pre-analytical 3.9 Very high LEICA THERMOFISHER SAKURA

    H&E 6.1 High THERMOFISHER LEICA MERCK

    Special stains 1.9 High MERCK DAKO -

    IHC 9.5 High ROCHE LEICA DAKO

    ISH 1.4 High ROCHE DAKO ABBOTT

    Others 1.3 Mid LEICA DAKO THERMOFISHER

    Trends and drivers

    Overall TD • Tissue diagnostics market is driven by increasing prevalence of cancer. Advanced tests like IHC is increasing
    due to expansion of public reimbursement and increase of cancer prevalence, IHC tests in certain hospitals are
    now under public reimbursement coverage. ISH reagent market is increasing due to targeted cancer therapy
    but ISH is not under public reimbursement and is much more expensive than IHC
    TD share changes across APAC in • Top 5 competitors in descending order of market share across APAC: Danaher, Roche, Thermofisher, Agilent
    2017 and Maixin (CN)

    Note
    - All market sizes are ex-manufacture price (not hospital buying price)
    - Instrument sales are included in all product segments
    - “Pre-analytical” includes tissue processors, embedding centers, sectioning centers, cryostats (for frozen tissue blocks), cover slides & slips
    - Level of growth rates are defined as such: Low: 0-5%, Mid: 5.1-10%, High: 10.1-15% and Very High: >15%
    Sources: Clearstate interviews and analysis

    HEALTHCARE redefined: from INSIGHTS to STRATEGY 10

    You might also like